Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Drug Farm

Drug Farm Signs Agreement with National Institutes of Health (NIH) to Develop Precision Targeted Treatment for ROSAH Syndrome
From Drug Farm
Via Business Wire
Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients
From Drug Farm
Via Business Wire
Drug Farm Announces anti-HBV immunomodulator, DF-006 is Accepted as a Late-Breaking Presentation at the 2024 European Association for the Study of the Liver Conference
From Drug Farm
Via Business Wire
Drug Farm Receives Rare Pediatric Disease Designation from the U.S. FDA for DF-003 to Treat ROSAH Syndrome
From Drug Farm
Via Business Wire
Drug Farm Doses First Patient in Part 3 of Phase 1 Chronic Hepatitis B Trial
From Drug Farm
Via Business Wire
Drug Farm Doses First Patient in Phase 1 Trial for ALPK1 Inhibitor, DF-003
From Drug Farm
Via Business Wire
Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1 Initiation for First-in-Class Oral ALPK1 Selective Kinase Inhibitor, DF-003
From Drug Farm
Via Business Wire
Drug Farm Raises $27M USD Financing for Advancement of First-In-Class Hepatitis B and Cardiovascular-Renal Drugs into Clinical Trials
From Drug Farm
Via Business Wire
Drug Farm Appoints Dr. Jeysen Yogaratnam as Chief Medical Officer
From Drug Farm
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.